Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Fr | Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc. | 217 | GlobeNewswire (Europe) | SHANNON, Ireland, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Irish medical device company Biomimetic Innovations Limited, an affiliate of PBC Biomed, today announced the execution of an exclusive license and... ► Artikel lesen | |
Di | Sanara MedTech expects Q4 revenue in the range of $25.7M to $26.2M | 5 | Seeking Alpha | ||
Di | Sanara MedTech reshapes executive team with new CFO and CAO | 2 | Investing.com | ||
Di | Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024 | 261 | GlobeNewswire (Europe) | Fourth Quarter Net Revenue Expected to Increase 45% to 48% Year-Over-Year; Full Year Net Revenue Expected to Increase 32% to 33% Year-Over-Year FORT WORTH, TX, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Sanara... ► Artikel lesen | |
SANARA MEDTECH Aktie jetzt für 0€ handeln | |||||
Di | Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd | 284 | GlobeNewswire (Europe) | OsStic® and related technologies represent differentiated solutions that address an estimated 100,000+ procedures in the U.S. annually(1); arrangement leverages Sanara's existing call points and commercial... ► Artikel lesen | |
Di | Sanara MedTech Inc. Expands Executive Leadership Team with New Appointments | 1 | GlobeNewswire (USA) | ||
Di | Sanara MedTech Inc. - 8-K, Current Report | - | SEC Filings | ||
04.12.24 | Sanara MedTech Inc. - 8-K, Current Report | - | SEC Filings | ||
12.11.24 | Sanara MedTech Inc. Reports Third Quarter 2024 Results | 121 | GlobeNewswire (Europe) | FORT WORTH, TX, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology... ► Artikel lesen | |
12.11.24 | Sanara MedTech Inc. - 8-K, Current Report | - | SEC Filings | ||
07.10.24 | Sanara MedTech Inc. Announces Changes to Its Board of Directors | 1 | GlobeNewswire (USA) | ||
23.09.24 | Sanara MedTech Inc. signs CEO Nixon to new employment terms | 1 | Investing.com | ||
23.09.24 | Sanara MedTech Inc. - 8-K, Current Report | 2 | SEC Filings | ||
11.09.24 | Sanara MedTech Inc. - 8-K, Current Report | 1 | SEC Filings | ||
11.09.24 | Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC | 1 | GlobeNewswire (USA) | ||
12.08.24 | Sanara MedTech Inc. - 8-K, Current Report | 1 | SEC Filings | ||
12.08.24 | Sanara MedTech GAAP EPS of -$0.41 misses by $0.20, revenue of $20.2M beats by $1.1M | 1 | Seeking Alpha | ||
12.08.24 | Sanara MedTech Inc. Announces Second Quarter 2024 Results | 193 | GlobeNewswire (Europe) | FORT WORTH, TX, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQ: SMTI), a medical technology... ► Artikel lesen | |
13.05.24 | Sanara MedTech Inc. Announces First Quarter 2024 Results | 248 | GlobeNewswire (Europe) | FORT WORTH, TX, May 13, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQ: SMTI), a medical technology... ► Artikel lesen | |
05.04.24 | Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer | 223 | GlobeNewswire (Europe) | FORT WORTH, TX, April 05, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. ("Sanara," the "Company," "we," "our" or "us") (NASDAQ: SMTI), a medical technology... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 36,720 | -0,22 % | DAX-Check LIVE: Fresenius, Hypoport, Kontron, Lanxess, Nemetschek, Nordex, Porsche AG, RWE, SAP & Co | Der DAX hat gestern die nächste Tausendermarke übersprungen. Erstmalig überwand er 21.000 Punkte. Am Ende des Tages ging er knapp darunter aus dem Handel. Das Tagesplus betrug 0,42 Prozent. Worauf es... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 53,48 | -1,58 % | Siemens Healthineers-Aktie: Kurs klettert leicht (53,42 €) | Am deutschen Aktienmarkt liegt das Wertpapier von Siemens Healthineers aktuell im Plus. Die Aktie kostete zuletzt 53,42 Euro. Die Aktie von Siemens Healthineers verzeichnet gegenwärtig einen Wertanstieg... ► Artikel lesen | |
CARL ZEISS MEDITEC | 56,30 | +6,03 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 40 Euro auf "Underweight" belassen. Das erste Geschäftsquartal dürfte mau ausfallen... ► Artikel lesen | |
GERRESHEIMER | 64,85 | +1,25 % | Gerresheimer Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
FRESENIUS MEDICAL CARE | 46,650 | +0,09 % | Fresenius Medical Care Aktie: Anerkennung durch starke Leistung! | Die Aktie von Fresenius Medical Care (FMC) verzeichnete am Handelstag einen bemerkenswerten Aufschwung mit einem Kursanstieg von 4,7 Prozent auf 46,53 Euro. Das Handelsvolumen belief sich auf 322.800... ► Artikel lesen | |
ECKERT & ZIEGLER | 53,30 | +5,96 % | Eckert&Ziegler-Aktie setzt Höhenflug fort! | Eckert&Ziegler-Aktien konnten am Freitag zulegen und waren mit einem Tagesgewinn von 5,96% Prozent der Top-Performer im SDAX. "Die Eckert & Ziegler Gruppe gehört zu den weltweit größten Herstellern... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 73,51 | +5,56 % | How Is The Market Feeling About PROCEPT BioRobotics? | ||
GENEDX | 79,18 | +1,96 % | GeneDx Announces Preliminary 2024 Financial Results | STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported preliminary financial results for... ► Artikel lesen | |
ALLURION TECHNOLOGIES | 8,430 | +161,80 % | Pre-market Movers: Allurion Technologies, Nvni Group, Dogwood Therapeutics, Jupiter Neurosciences, Ctrl Group | BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 08.15 A.M. ET).In the Green Allurion Technologies Inc. (ALUR) is up over 297%... ► Artikel lesen | |
INTUITIVE SURGICAL | 557,50 | +0,18 % | Opening Bell: Bitcoin, Gold, Novo Nordisk, Oracle, Meta, Alphabet, Intuitive Surgical, Boeing | Per Videoschalte umriss Donald Trump gestern beim Wirtschaftstreffen in Davos sein Wirtschaftsprogramm. Dies sorgte für gute Stimmung an der Börse. Der Dow Jones legte 0,92 Prozent zu, der Nasdaq 100... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 22,830 | +5,94 % | BrightSpring Health Services, Inc. Enters into Definitive Agreement to Divest Community Living Business to Sevita; Reports Preliminary 2024 Financial Results and Provides 2025 Guidance Excluding Community Living | Streamlined organization and Provider Services segment to optimize resource allocationProvider Services focus on Home Health/Hospice, Personal Care, Rehabilitation Services, and Care Management strategic... ► Artikel lesen | |
PROGYNY | 22,075 | +0,25 % | Witness A Substantial Acquisition As DEBRA MORRIS Acquires Progyny Stock Options Worth $37K | ||
BIOTEST | 26,900 | +0,37 % | Aktien KW 2 - US-Jobmarkt verdirbt die Party? Woche mit Paukenschlag. News. Auto1. Mutares. Nvidia. Kion. Magirus. Fuchs. INDUS. Biotest. Circus | Aktien Wochenrückblick - nach zwei ruhigen feiertagsgeprägten Wochen sah es diese Woche wieder so aus, als ob der DAX wieder auf Rekordkurs gehen wollte. Angebrannt ist nichts, aber die US-Jobdaten... ► Artikel lesen | |
HIMS & HERS HEALTH | 29,370 | -0,17 % | Why Hims & Hers Health, Inc. (HIMS) Is Skyrocketing Now | ||
NANO-X IMAGING | 8,240 | -5,83 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen |